These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8144439)

  • 1. Synergy testing of macrolide combinations using the chequerboard technique.
    MacGowan AR; Bowker K; Bedford KA; Holt HA; Reeves DS
    J Antimicrob Chemother; 1993 Dec; 32(6):913-5. PubMed ID: 8144439
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility testing of Haemophilus influenzae to clarithromycin.
    Paton R; Arnold J; Cockburn J; Emmanuel FX
    J Antimicrob Chemother; 2000 Apr; 45(4):529-31. PubMed ID: 10747833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model.
    Walker KJ; Larsson AJ; Zabinski RA; Rotschafer JC
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2003-7. PubMed ID: 7811010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
    Hoogkamp-Korstanje JA; Dirks-Go SI; Kabel P; Manson WL; Stobberingh EE; Vreede RW; Davies BI
    J Antimicrob Chemother; 1997 Mar; 39(3):411-4. PubMed ID: 9096192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of methods for testing the susceptibility of Haemophilus influenzae to clarithromycin.
    Barry AL; Schultheiss TS; Brown SD; Fuchs PC
    J Antimicrob Chemother; 1996 Apr; 37(4):845-7. PubMed ID: 8722555
    [No Abstract]   [Full Text] [Related]  

  • 6. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.
    Cederbrant G; Kahlmeter G; Schalén C; Kamme C
    J Antimicrob Chemother; 1994 Dec; 34(6):1025-9. PubMed ID: 7730216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spiramycin alone and in combination with trimethoprim against Haemophilus influenzae.
    Arditi M; Yogev R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():57-62. PubMed ID: 3263355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A).
    Seyama S; Wajima T; Suzuki M; Ushio M; Fujii T; Noguchi N
    J Antimicrob Chemother; 2017 Mar; 72(3):948-949. PubMed ID: 27999037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-microbial sensitivities of bacteria isolated from patients with chronic lower respiratory tract infection under long-term macrolide therapy].
    Maeda K; Mikasa K
    Jpn J Antibiot; 2001 Dec; 54 Suppl C():106-8. PubMed ID: 12575432
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.
    Fuchs PC; Barry AL; Brown SD
    J Clin Microbiol; 2001 Jan; 39(1):43-6. PubMed ID: 11136745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactericidal tests.
    Dabernat H; Delmas C; Seguy M; Fourtillan JB; Girault J; Lareng MB
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():19-30. PubMed ID: 1827099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.
    Burgess DS; Hastings RW; Horan JL
    Ann Pharmacother; 1999 Dec; 33(12):1262-5. PubMed ID: 10630825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a novel series of acylides active against community-acquired respiratory pathogens.
    Pandya M; Chakrabarti A; Rathy S; Katoch R; Venkataraman R; Bhateja P; Mathur T; Kumar GR; Malhotra S; Rao M; Bhadauria T; Barman TK; Das B; Upadhyay D; Bhatnagar PK
    Int J Antimicrob Agents; 2010 Aug; 36(2):169-74. PubMed ID: 20493666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S.
    Peric M; Bozdogan B; Galderisi C; Krissinger D; Rager T; Appelbaum PC
    J Antimicrob Chemother; 2004 Aug; 54(2):393-400. PubMed ID: 15243030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
    Bogdanovich T; Bozdogan B; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite A-62671 against Haemophilus influenzae.
    Olsson-Liljequist B; Hoffman BM
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():11-7. PubMed ID: 1827097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Haemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metabolite.
    Barry AL; Fuchs PC; Pfaller MA
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1080-1. PubMed ID: 1839381
    [No Abstract]   [Full Text] [Related]  

  • 18. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-bacterial and anti-inflammatory actions of clarithromycin against Haemophilus influenzae that has infiltrated the respiratory epithelial cells].
    Yamazaki Y; Tanabe T; Ushiki A; Kubo K
    Jpn J Antibiot; 2009 Mar; 62 Suppl A():48-51. PubMed ID: 22452055
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro cidal activity of clarithromycin and its 14-hydroxy metabolite (A-62671) against Haemophilus influenzae.
    Powell M; Chen HY; Weinhardt B; Williams JD
    J Antimicrob Chemother; 1991 May; 27(5):694-6. PubMed ID: 1832146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.